Afibrinogenemia
What's New
Last Posted: Mar 07, 2023
- Mutational Epidemiology of Congenital Fibrinogen Disorders.
Casini Alessandro, et al. Thrombosis and haemostasis 2018 0 (11) 1867-1874 - Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations.
Wypasek Ewa, et al. Thrombosis research 2019 0 133-140 - Correction to: Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani population.
Naz Arshi, et al. Thrombosis journal 2019 0 5 - Molecular and clinical profile of congenital fibrinogen disorders in Iran, identification of two novel mutations.
Tavasoli Behnaz, et al. International journal of laboratory hematology 2020 0 (5) 619-627 - Clinical features and genetic defect in six index patients with congenital fibrinogen disorders: Three novel mutations with one common mutation in Taiwan's population.
Shen Ming-Ching, et al. Haemophilia : the official journal of the World Federation of Hemophilia 2021 0 (6) 1022-1027 - Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders.
Mohsenian Samin, et al. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2021 0 (6) 103203 - Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders.
Dorgalaleh Akbar, et al. Seminars in thrombosis and hemostasis 2022 0 (3) 344-355 - Diagnosis of congenital fibrinogen disorders.
Lebreton Aurélien, et al. Annales de biologie clinique 2016 8 (4) 405-412 - Afibrinogenemia
From NCATS Genetic and Rare Diseases Information Center
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: